COMMUNIQUÉS West-GlobeNewswire

AveXis Provides Update on Proposed Acquisition by Novartis AG
01/05/2018
CHICAGO, May 01, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, [...]
Novartis provides update on proposed acquisition of AveXis
01/05/2018
Basel, May 1 , 2018 - Novartis AG (NYSE: NVS) ("Novartis") today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") applicable to Novartis' cash [...]
Medibio Launches Global Corporate Mental Health Product
01/05/2018
Release of first commercially available mental health technology product Notable existing support from key Australian companies Provide organizations with cost savings by reducing mental health burden SYDNEY, Australia [...]
Lexington Releases Audited Consolidated Financial Statements
01/05/2018
VANCOUVER, British Columbia, April 30, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, has released its audited [...]
MacroGenics Announces Date of First Quarter 2018 Financial Results Conference Call
01/05/2018
ROCKVILLE, MD, April 30, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX) today announced that on Monday, May 7, 2018, the Company will release its financial results for the quarter ended March 31, 2018. The [...]
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2018
CAMBRIDGE, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]
Immucor Announces FDA Clearance for Echo Lumena(TM); Next Generation, Fully Automated Instrument Powers Smaller to Mid-Volume Labs
30/04/2018
Faster, clearer blood compatibility results now available NORCROSS, Ga., April 30, 2018 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that its next [...]
Helix BioPharma Corp. Closes Private Placement
30/04/2018
RICHMOND HILL, Ontario, April 30, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP ) (FSE:HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Forward Pharma Reports Full-Year 2017 Financial and Operational Results
30/04/2018
COPENHAGEN, Denmark, April 30, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq: FWP ) (“We” or “Forward” or the “Company”), today reported financial results for the year ended December 31, 2017. Net income for the [...]
Flexion Therapeutics to Report First-Quarter 2018 Financial Results on May 8, 2018
30/04/2018
BURLINGTON, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced that it will report its first-quarter 2018 financial results after the close of the U.S. financial markets [...]
Portola Pharmaceuticals to Announce First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018
30/04/2018
SOUTH SAN FRANCISCO, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA ) announced today that it will host a webcast and conference call to discuss the Company’s financial results [...]
Golden Leaf Reports Fiscal Year 2017 Results
30/04/2018
TORONTO, April 30, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced its [...]
AzurRx BioPharma Announces Proposed Public Offering of Common Stock
30/04/2018
BROOKLYN, N.Y., April 30, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma (NASDAQ: AZRX ), (“AzurRx” or the “Company”), announced today that it intends to offer and sell shares of its common stock in an underwritten public [...]
Novartis receives FDA approval of Tafinlar® + Mekinist® for adjuvant treatment of BRAF V600-mutant melanoma
30/04/2018
Tafinlar + Mekinist is the first oral targeted adjuvant combination therapy to demonstrate significant clinical benefit in patients with a BRAF V600 mutation, following complete surgical resection Tafinlar + Mekinist [...]
National Brain Tumor Society Stresses Urgent Patient Needs and Experiences During Brain Tumor Awareness Month 2018
30/04/2018
Largest brain tumor nonprofit in the U.S. rallies supporters to raise their voices in support of the brain tumor community BOSTON, April 30, 2018 (GLOBE NEWSWIRE) -- National Brain Tumor Society (NBTS), the largest [...]
New Novartis Phase III data for brolucizumab demonstrate reliability of 12-week treatment interval
30/04/2018
Patients identified for brolucizumab 12-week treatment interval in Phase III HAWK and HARRIER trials had an 87% and 83% probability of successfully continuing on a 12-week interval through week 48 Predictability data [...]
miRagen Therapeutics to Participate in Upcoming Investor Conferences
30/04/2018
BOULDER, Colo., April 30, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN ), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today [...]
AxoGen, Inc. Reports 2018 First Quarter Financial Results
30/04/2018
Record Q1 Revenue of $17.3 million, representing 41% growth over prior year ALACHUA, Fla., April 30, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical [...]
Eloxx Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
30/04/2018
WALTHAM, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”) (Nasdaq: ELOX ) today announced the completion of its previously announced underwritten public offering of 5,899,500 shares of its [...]

Pages